Drug details
Juvisync (sitagliptin and simvastatin)
type of
Juvisync (sitagliptin and simvastatin) is a combination of an oral diabetes medicine and an HMG CoA reductase inhibitor, or "statin," for people with type 2 diabetes who also have high cholesterol or triglycerides (types of fat) in the blood. Juvisync is not for treating type 1 diabetes. Juvisync is also used to lower the risk of stroke, heart attack, and other heart complications in people with diabetes, coronary artery disease, or other risk factors. The brand name Juvisync is discontinued, but generic versions may be available.
The drug is often used to treat Diabetes , Type 2 diabetes .
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- loss of appetite,
- itching,
- vomiting,
- fever,
- weight loss,
- confusion,
- clay-colored stools,
- yellowing of the skin or eyes (jaundice),
- blurred vision,
- weight gain,
- dry mouth,
- swelling,
- weakness,
- unusual tiredness,
- sore throat,
- little or no urination,
- increased thirst,
- increased urination,
- fruity breath odor,
- dark colored urine,
- drowsiness,
- fast heart rate,
- hunger,
- memory problems,
- dry skin,
- burning in your eyes, and
- muscle pain and tenderness,
- abdominal pain spreading to your back,
- skin pain followed by a red or purple skin rash that causes blistering and peeling
The following drugs are related to Juvisync, either as a replacement or used together:
- Zegalogue (dasiglucagon injection)